Clinical Research Directory
Browse clinical research sites, groups, and studies.
New CSF Biomarkers for Alzheimer's Disease
Sponsor: Central Hospital, Nancy, France
Summary
Today, the Alzheimer's disease (AD) diagnosis is founded not only on clinical criteria but also on complementary examinations to confirm a physiopathological process of AD. In complex cases, lumbar punction could be necessary in order to measure Aβ peptides and Total and phosphorylated Tau but new biomarkers could be useful. The main objective of this project is to conserve these cerebrospinal fluids, collected in usual practice in order to validate new biomarkers for diagnosis, prognosis or therapeutic following of Alzheimer's disease and other dementia.
Official title: New Diagnosis or Prognosis Biomarkers for Alzheimer's Disease: Biobank of CSF Collected as Part of Differential Diagnosis of Dementia
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
50000
Start Date
2013-07-12
Completion Date
2050-12-31
Last Updated
2024-03-06
Healthy Volunteers
No
Locations (1)
CHRU De Nancy
Nancy, Grand Est, France